Abbott Laboratories (ABT)
NYSE: ABTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:02 PM ET · Delayed 15 min
ABT stock chart
Technical analysisKey statistics
All statistics- Market cap
- $170.84B
- P/E (TTM)
- 31.64
- Forward P/E
- 16.28
- EPS (TTM)
- $3.12
- Dividend yield
- 2.51% ($2.48)
- Ex-dividend date
- Jul 15, 2026
- 52-week range
- 81.97 – 135.13
- Day range
- 97.62 – 99.37
- Volume / Avg
- 9.03M / 9.56M
- Beta
- —
- Shares outstanding
- 1.73B
- Next earnings
- Oct 21, 2026
52-week range
ABT stock today
Abbott Laboratories (ABT) closed at $98.73 on Oct 7, up 0.58% (+$0.57), versus the S&P 500's 0.22% decline. Shares are 26.9% below their 52-week high of $135.13, set on Oct 9, 2025 and 20.4% above the 52-week low of $81.97, in the middle of the past year's range. ABT is down 21.2% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 25.8%.
At 31.6x trailing earnings, Abbott Laboratories trades above the peer-group median of 21.0x. Its forward P/E of 16.3x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. The company is scheduled to report Sep/2026 results on Oct 21 before the market opens; analysts expect EPS of $1.43. Abbott Laboratories pays an annual dividend of $2.48 per share, a 2.51% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About Abbott Laboratories
Company profileAbbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Robert B. Ford
- Headquarters
- Abbott Park, IL
- Employees
- 122,000
- Website
- abbott.com
Financial highlights
Full financialsIn fiscal 2025, Abbott Laboratories generated $44.33 billion in revenue, up 5.7% from fiscal 2024, its 2nd consecutive year of revenue growth. Net income was $6.52 billion (-51.3% year over year), for a net margin of 14.7% versus a median of 15.9% in the prior 5 years. Gross margin was 56.4% (up from 55.4%) and operating margin 18.2%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $44.33B | $41.95B | $40.11B | $43.65B | $43.08B |
| Growth | +5.67% | +4.59% | -8.12% | +1.34% | +24.47% |
| Net income | $6.52B | $13.40B | $5.72B | $6.93B | $7.07B |
| EPS (diluted) | $3.72 | $7.64 | $3.26 | $3.91 | $3.94 |
Analyst forecast
ForecastConsensus (28 analysts)
strong_buy
Avg. price target
$120.72+22.27%
- Strong buy 5
- Buy 19
- Hold 4
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Oct 21, 2026
- EPS estimate
- $1.43
- Last reported (Q1 2026)
- Apr 29, 2026
- EPS actual vs est.
- $0.61 vs —
Dividends
Dividend history- Annual dividend
- $2.48
- Dividend yield
- 2.51%
- Last payment
- $0.63
- Ex-dividend date
- Jul 15, 2026
ABT news
All ABT news- Stryker, Abbott among Overweight ideas as Barclays turns bullish on MedTechSeeking AlphaABT, BCS, SYK
- Abbott (ABT) Stock Drops Despite Market Gains: Important Facts to NoteNasdaq
- Abbott Expands CardioMEMS System With FDA-Approved Patient Monitoring FeaturesNasdaq
- Abbott Receives FDA Approval For CardioMEMS HF System UpdatesNasdaq
- The Zacks Analyst Blog Highlights Abbott, Corcept, Precigen and Bausch Health CompaniesNasdaqABT, CORT, BHC, PGEN
- How to Create a Million-Dollar Stock PortfolioNasdaqWFC, ABT, ABBV
- Rothschild & Co Upgrades Abbott Laboratories to Buy from NeutralNasdaq
- Notable ETF Inflow Detected - SCHD, COP, ABT, BMYNasdaqSCHD, COP, ABT, BMY
Abbott Laboratories peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| NVONovo Nordisk A/S | 38.26 | +1.95% | $168.89B | vs ABT |
| VRTXVertex Pharmaceuticals Incorporated | 505.64 | +0.66% | $128.16B | vs ABT |
| BMYBristol-Myers Squibb Company | 59.70 | +0.18% | $121.95B | vs ABT |
| SNYSanofi ADS | 40.20 | +1.62% | $96.32B | vs ABT |
| AZNAstraZeneca PLC | 160.12 | +0.95% | $248.33B | vs ABT |
| REGNRegeneron Pharmaceuticals Inc. | 742.12 | +0.46% | $76.40B | vs ABT |
| NVSNovartis AG | 143.28 | +1.77% | $272.33B | vs ABT |
| ONCBeOne Medicines Ltd. ADR | 364.02 | +0.34% | $41.41B | vs ABT |
Indexes, lists and sector
Index membership
Appears in lists
Abbott Laboratories stock FAQ
What is Abbott Laboratories's stock price today?
ABT last traded at $98.73 as of Oct 7, 4:02 PM EDT, up 0.58% on the day. Prices are delayed at least 15 minutes.
Does Abbott Laboratories pay a dividend?
Yes. Abbott Laboratories pays $2.48 per share annually, a 2.51% yield. The most recent dividend of $0.63 had an ex-dividend date of Jul 15, 2026.
When is Abbott Laboratories's next earnings date?
Abbott Laboratories is expected to report earnings on Wednesday, October 21, 2026. Analysts expect EPS of $1.43.
What is ABT's P/E ratio?
ABT trades at a trailing P/E ratio of 31.64 and a forward P/E of 16.28, compared with a median of 21.0 for its closest peers.
Is Abbott Laboratories in the S&P 500?
Yes. Abbott Laboratories (ABT) is a constituent of the S&P 500 index.
Who is Abbott Laboratories's CEO?
Mr. Robert B. Ford is the chief executive officer of Abbott Laboratories, which has about 122,000 employees.
Has ABT ever split its stock?
Yes. The most recent ABT stock split was a 10000-for-4798 split on Jan 2, 2013, one of 7 splits on record.